NCT03872947 2025-08-03A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsToray Industries, IncPhase 1 Active not recruiting138 enrolled
NCT03044613 2025-03-06Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Active not recruiting32 enrolled
NCT02931890 2024-05-02CRITICS-IIThe Netherlands Cancer InstitutePhase 2 Active not recruiting207 enrolled